Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (191-200 of 309) with videos related to

Pageof 31
Sort By:
The Lancet. HIV|August 6, 2021
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trialJhon Rojas, Elisa de Lazzari, Eugenia Negredo, et al.
BMC Infectious Diseases|May 4, 2023
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analysesRodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, et al.
One Health (Amsterdam, Netherlands)|June 26, 2023
Methicillin-resistant and methicillin-sensitive <i>Staphylococcus aureus</i> in pork industry workers, Catalonia, SpainSara Quero, Marina Serras-Pujol, Noemí Párraga-Niño, et al.
International Journal of Environmental Research and Public Health|July 20, 2021
Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource SavingsFrancesc López Seguí, Jose Maria Navarrete Duran, Albert Tuldrà, et al.
Plos One|August 13, 2013
HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalizationChristian Pou, Francisco M Codoñer, Alexander Thielen, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South AfricaJonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
Antiviral Research|March 1, 2022
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysisMartin Sachse, Raquel Tenorio, Isabel Fernández de Castro, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 15, 2024
Deep-amplicon sequencing of the complete beta-tubulin gene in Trichuris trichiura before and after albendazole treatmentJavier Gandasegui, Berta Grau-Pujol, Valdemiro Novela, et al.
The Journal of Infectious Diseases|July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral TherapySilvia Bernal, Maria C Puertas, Sara Morón-López, et al.
Pageof 31

Showing results (191-200 of 309) with videos related to

Sort By:
Pageof 31
The Lancet. HIV|August 6, 2021
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trialJhon Rojas, Elisa de Lazzari, Eugenia Negredo, et al.
BMC Infectious Diseases|May 4, 2023
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analysesRodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, et al.
One Health (Amsterdam, Netherlands)|June 26, 2023
Methicillin-resistant and methicillin-sensitive <i>Staphylococcus aureus</i> in pork industry workers, Catalonia, SpainSara Quero, Marina Serras-Pujol, Noemí Párraga-Niño, et al.
International Journal of Environmental Research and Public Health|July 20, 2021
Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource SavingsFrancesc López Seguí, Jose Maria Navarrete Duran, Albert Tuldrà, et al.
Plos One|August 13, 2013
HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalizationChristian Pou, Francisco M Codoñer, Alexander Thielen, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South AfricaJonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
Antiviral Research|March 1, 2022
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysisMartin Sachse, Raquel Tenorio, Isabel Fernández de Castro, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 15, 2024
Deep-amplicon sequencing of the complete beta-tubulin gene in Trichuris trichiura before and after albendazole treatmentJavier Gandasegui, Berta Grau-Pujol, Valdemiro Novela, et al.
The Journal of Infectious Diseases|July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral TherapySilvia Bernal, Maria C Puertas, Sara Morón-López, et al.
Pageof 31